| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 57 |
| 1 | ASPIRIN | 25 |
| 2 | CLOPIDOGREL | 22 |
| 3 | WARFARIN | 22 |
| 4 | ASPIRIN 325 MG | 21 |
| 5 | ASPIRIN 81 MG | 21 |
| 6 | ENOXAPARIN SODIUM | 21 |
| 7 | BISOPROLOL FUMARATE | 17 |
| 8 | METOPROLOL | 15 |
| 9 | METOPROLOL TARTRATE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FACTOR XIII CONCENTRATE (HUMAN) | 3 | 0.0330 |
| 1 | HUMAN FIBRINOGEN, HUMAN THROMBIN | 1 | 0.0172 |
| 2 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE | 1 | 0.0065 |
| 3 | TROLAMINE SALICYLATE | 1 | 0.0052 |
| 4 | VON WILLEBRAND FACTOR (RECOMBINANT) | 1 | 0.0032 |
| 5 | TAURINE | 1 | 0.0013 |
| 6 | MECASERMIN | 1 | 0.0012 |
| 7 | TALQUETAMAB-TGVS | 1 | 0.0007 |
| 8 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 9 | BAYER ASPIRIN EXTRA STRENGTH | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 70 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 27 |
| 3 | Corticosteroid [EPC] | 22 |
| 4 | Loop Diuretic [EPC] | 17 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 13 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 13 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 12 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 12 |
| 9 | Kinase Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 6 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 3 | Factor Xa Inhibitor [EPC] | 70 | 0.0003 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 4 | 0.0002 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 6 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 8 | Alkaloid [EPC] | 4 | 0.0002 |
| 9 | GLP-2 Analog [EPC] | 2 | 0.0001 |